Notice of alternative medication authorization, June 29 and 30, 2026

This notice was published on July 24, 2026.

Semaglutide 9 mg replaces Rybelsus 14 mg (in force on June 29) and Semaglutide 4 mg replaces Rybelsus 7 mg (in force on June 30).